1. Home
  2. CVEO vs AVXL Comparison

CVEO vs AVXL Comparison

Compare CVEO & AVXL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Civeo Corporation (Canada)

CVEO

Civeo Corporation (Canada)

N/A

Current Price

$33.56

Market Cap

297.0M

ML Signal

N/A

Logo Anavex Life Sciences Corp.

AVXL

Anavex Life Sciences Corp.

N/A

Current Price

$2.76

Market Cap

251.1M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
CVEO
AVXL
Founded
1977
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
297.0M
251.1M
IPO Year
2013
2013

Fundamental Metrics

Financial Performance
Metric
CVEO
AVXL
Price
$33.56
$2.76
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
3
Target Price
$37.00
$22.00
AVG Volume (30 Days)
68.5K
879.2K
Earning Date
05-01-2026
05-08-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$7.72
N/A
Revenue Next Year
$5.61
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$19.75
$2.61
52 Week High
$36.50
$13.99

Technical Indicators

Market Signals
Indicator
CVEO
AVXL
Relative Strength Index (RSI) 59.75 36.01
Support Level $24.96 $2.61
Resistance Level $34.80 $3.50
Average True Range (ATR) 1.45 0.17
MACD -0.02 -0.03
Stochastic Oscillator 50.92 16.56

Price Performance

Historical Comparison
CVEO
AVXL

About CVEO Civeo Corporation (Canada)

Civeo Corp provides hospitality services to the natural resources industry in Canada, Australia. The company provides a full suite of services for guests, including lodging, catering and food service, housekeeping and maintenance at accommodation facilities that the company or its customers own. The company provides services that support the day-to-day operations of these facilities, such as laundry, facility management and maintenance, water and wastewater treatments, power generation, communication systems, security and logistics. The company operates in active oil, metallurgical coal, liquefied natural gas and iron ore-producing regions. The company operates in three reportable business segments Canada, and Australia. It derives maximum revenue from Australia.

About AVXL Anavex Life Sciences Corp.

Anavex Life Sciences Corp is a clinical stage biopharmaceutical company engaged in the development of differentiated therapeutics by applying precision medicine to central nervous system(CNS) diseases with high unmet need. It analyzes genomic data from clinical trials to identify biomarkers, which are used in the analysis of its clinical trials for the treatment of neurodegenerative and neurodevelopmental diseases. The company focuses on developing treatments for Alzheimer's disease, Parkinson's disease, schizophrenia, neurodevelopmental, neurodegenerative, and rare diseases, including Rett syndrome, and other central nervous system (CNS) disorders. Its pipeline includes ANAVEX 2-73 and ANAVEX 3-71 and several other compounds in different stages of clinical and pre-clinical development.

Share on Social Networks: